COX10 antibodies are pivotal in studying mitochondrial disorders, immune cell metabolism, and oxidative phosphorylation (OXPHOS):
Muscle-Specific COX10 Knockout (KO) Mice:
NK-Specific COX10 Deletion (Ncr1-Cox10 Δ/Δ Mice):
T Cells: COX10 is critical for T cell quiescence exit and activation .
Endothelial Cells: COX10 deletion prevents metabolic switch to OXPHOS, impairing angiogenesis .
Mutations in COX10 are linked to mitochondrial disorders, including:
Leigh Syndrome: Neurodegeneration, lactic acidosis, and COX deficiency .
Cardiomyopathy: Fatal infantile hypertrophic cardiomyopathy .
Tubulopathy and Leukodystrophy: Renal and white matter abnormalities .
Diagnostic Use: COX10 antibodies aid in detecting protein levels in patient fibroblasts or tissue biopsies to confirm COX assembly defects .
Sample Preparation: Use mitochondrial-enriched fractions for WB .
Controls: Include positive controls like fetal lung lysate (Avantor) or HEK293T cells overexpressing COX10 .
Limitations:
Functional Characterization of COX10: